| Primary |
| Urinary Tract Infection |
15.6% |
| Completed Suicide |
9.7% |
| Type 2 Diabetes Mellitus |
8.4% |
| Hiv Infection |
7.2% |
| Hypertension |
7.2% |
| Infection |
7.2% |
| Prophylaxis |
5.1% |
| Hiv Test Positive |
4.2% |
| Prophylaxis Against Hiv Infection |
3.8% |
| Skin Infection |
3.8% |
| T-cell Type Acute Leukaemia |
3.8% |
| Tenosynovitis |
3.4% |
| Acne |
3.0% |
| Depression |
3.0% |
| Acute Lymphocytic Leukaemia |
2.5% |
| Antibiotic Prophylaxis |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Cellulitis |
2.5% |
| Herpes Zoster |
2.5% |
| Diabetes Mellitus |
2.1% |
|
| Drug Hypersensitivity |
24.7% |
| Rash |
7.6% |
| Urticaria |
7.0% |
| Vomiting |
6.3% |
| Pruritus |
5.7% |
| Thrombocytopenia |
5.7% |
| Hypersensitivity |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Completed Suicide |
3.8% |
| Drug Screen False Positive |
3.8% |
| Hypoglycaemia |
3.2% |
| Pyrexia |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Nausea |
2.5% |
| No Adverse Event |
2.5% |
| Rash Generalised |
2.5% |
| Skin Exfoliation |
2.5% |
| Anaphylactic Reaction |
1.9% |
| Drug Ineffective |
1.9% |
| Feeling Abnormal |
1.9% |
|
| Secondary |
| Tenosynovitis |
16.0% |
| Drug Use For Unknown Indication |
10.8% |
| Hiv Infection |
9.1% |
| Prophylaxis |
9.1% |
| Renal Transplant |
5.9% |
| Depression |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Hypertension |
4.5% |
| Urinary Tract Infection |
4.2% |
| Cystic Fibrosis |
3.5% |
| Diarrhoea |
3.5% |
| Tuberculosis |
3.5% |
| Insomnia |
3.1% |
| Pain |
3.1% |
| Antiretroviral Therapy |
2.8% |
| Infection |
2.8% |
| Completed Suicide |
2.1% |
| Constipation |
2.1% |
| Immunosuppression |
2.1% |
| Infection Prophylaxis |
2.1% |
|
| Drug Hypersensitivity |
33.3% |
| Vomiting |
11.9% |
| Human Herpesvirus 6 Infection |
4.8% |
| Hypophagia |
4.8% |
| Splenic Infarction |
4.8% |
| Neutropenia |
3.6% |
| Pyrexia |
3.6% |
| Rash Generalised |
3.6% |
| Urinary Tract Infection |
3.6% |
| Febrile Neutropenia |
2.4% |
| Hallucination |
2.4% |
| Hypersensitivity |
2.4% |
| Kidney Transplant Rejection |
2.4% |
| Myalgia |
2.4% |
| Pain |
2.4% |
| Pneumonia |
2.4% |
| Renal Failure |
2.4% |
| Renal Tubular Necrosis |
2.4% |
| Skin Exfoliation |
2.4% |
| Stevens-johnson Syndrome |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.5% |
| Drug Use For Unknown Indication |
17.5% |
| Hiv Infection |
9.4% |
| Prophylaxis |
8.9% |
| Hypertension |
5.4% |
| Acute Lymphocytic Leukaemia |
4.6% |
| Multiple Myeloma |
4.4% |
| Prophylaxis Against Transplant Rejection |
4.2% |
| Renal Transplant |
3.7% |
| Depression |
2.7% |
| Liver Transplant |
2.2% |
| Pain |
2.1% |
| Infection Prophylaxis |
2.0% |
| Vitamin Supplementation |
1.8% |
| Premedication |
1.7% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Antifungal Prophylaxis |
1.7% |
| Nausea |
1.6% |
| Dyspepsia |
1.4% |
| Diabetes Mellitus |
1.3% |
|
| Vomiting |
10.1% |
| Urinary Tract Infection |
8.7% |
| Pyrexia |
7.8% |
| Weight Decreased |
7.8% |
| Death |
6.1% |
| Pneumonia |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Sepsis |
5.3% |
| Thrombocytopenia |
5.0% |
| Renal Failure Acute |
4.7% |
| Respiratory Failure |
4.2% |
| Multi-organ Failure |
3.9% |
| Ventricular Tachycardia |
3.9% |
| Wound Infection Staphylococcal |
3.9% |
| X-ray Abnormal |
3.9% |
| Urinary Retention |
3.1% |
| Deep Vein Thrombosis |
2.8% |
| Dyspnoea |
2.5% |
| Pregnancy |
2.5% |
| Ureteric Stenosis |
2.5% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
44.4% |
| Product Used For Unknown Indication |
11.1% |
| Drug Use For Unknown Indication |
8.3% |
| Gastrooesophageal Reflux Disease |
8.3% |
| Renal Transplant |
8.3% |
| Hiv Infection |
5.6% |
| Prophylaxis |
5.6% |
| Attention Deficit/hyperactivity Disorder |
2.8% |
| Bipolar I Disorder |
2.8% |
| Hypertension |
2.8% |
|
| Drug Interaction |
33.3% |
| Micturition Disorder |
22.2% |
| Dyspnoea |
11.1% |
| International Normalised Ratio Increased |
11.1% |
| Nephropathy Toxic |
11.1% |
| Vomiting |
11.1% |
|
